Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
Authors of this article:
Eva
Clemens1, 2
;
Annelot JM
Meijer1
;
Linda
Broer3
;
Thorsten
Langer4
;
Anne-Lotte LF
van der Kooi1, 2, 5
;
André G
Uitterlinden3
;
Andrica
de Vries1, 2
;
Claudia E
Kuehni6, 7
;
Maria L
Garrè8
;
Tomas
Kepak9, 10
;
Jarmila
Kruseova11
;
Jeanette F
Winther12, 13
;
Leontien C
Kremer1, 14
;
Eline
van Dulmen-den Broeder1, 15
;
Wim JE
Tissing1, 16
;
Catherine
Rechnitzer17
;
Line
Kenborg12
;
Henrik
Hasle18
;
Desiree
Grabow19
;
Ross
Parfitt20
;
Harald
Binder19, 21
;
Bruce C
Carleton22
;
Julianne
Byrne23
;
Peter
Kaatsch19
;
Antoinette
am Zehnhoff-Dinnesen20
;
Oliver
Zolk24
;
Marry M
van den Heuvel-Eibrink1
There are currently no tweets available for this article within the specified range.